Engineering Biology (EngBio) is an emerging field at the confluence of Biology, Chemistry, Engineering, AI and Data Science. It has the potential to provide innovative solutions to these challenges by ...
Environmental biotechnology is the branch of biotechnology that addresses environmental problems, such as the removal of pollution, renewable energy generation or biomass production, by exploiting ...
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
Regeneron, maker of the blockbuster ophthalmology medicine Eylea, has acquired an ocular biotech, the large biopharma confirmed to Endpoints News on Thursday.
No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...
2024 was the year of the private megaround. Nine-figure financings dominated biotech’s venture funding landscape, with 96 such rounds tallied by Endpoints News. The bevy … ...
Built by Biology just as Nature intended.” As of Sept. 30, 2024, the company had cash and cash equivalents of $25,297. Last week, the company entered into a securities purchase agreement with ...
A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
The predictive design of gene circuits in plants has been challenging and lagging behind other organisms. Here, the authors report a predictive framework for designing synthetic genetic circuits ...
Figure 1 Schematic diagram of CRISPR/Cas9 plant transformation vector pKSE401. Oligonucleotides of gRNA sequence were annealed and then inserted at the BsaI-digestion site between the pU6-26 promoter ...
Conduct your own due diligence and consult a financial adviser before making any investment decisions. No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception.